Skip To Main Content
Romain Barus on Muck Rack

Romain Barus

As seen in: Wiley Online Library, British Pharmacological Society
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Romain

Contact Romain, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Applying machine learning to pharmacovigilance data: A proof-of-concept study

|
By Romain Barus, Pauline Schiro, Jean-Luc Faillie
| British Pharmacological Society
What is already known about this subject Machine learning (ML) is used in specific clinical pharmacology areas like therapeutic drug monitoring. In pharmacovigilance, the feasibility of ML is not yet well-established. What this study adds We demonstrate that ML (eXtreme Gradient Boosting model) can be used on pharmacovigilance data to classify adverse drug reactions of interest.
Open in Who Shared Issue with article?

Distinct neuroinflammatory patterns between cerebral microbleeds and microinfarcts in cerebral amyloid angiopathy

|
By Laurent Puy, Univ. Lille, CHU Lille, Romain Barus
| Wiley Online Library Verified
Introduction Cerebral amyloid angiopathy (CAA) is a cerebral small vessel disease characterized by a widespread co-occurrence of microvascular hemorrhagic (cerebral microbleeds, CMBs) and ischemic (cerebral microinfarcts, MIs) lesions.1 These lesions are now widely considered as markers of the severity of the disease.
Open in Who Shared Issue with article?
See all 2 licensed articles (4 Total)